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Background: Trypanosoma brucei expresses a highly glycosylated surface coat that is essential for parasite survival.
Results: The T. brucei gene TbGT11 encodes an N-acetylglucosaminyltransferase I, the key enzyme for initiating the biosyn-
thesis of complex N-glycans.
Conclusion: T. brucei GnTI is not a homologue of metazoan GnTI, but a highly divergent enzyme belonging to the 3-glyco-
syltransferase family.
Significance: Deeper understanding of T. brucei N-glycosylation pathway.
Trypanosoma brucei expresses a diverse repertoire of N-gly-
cans, ranging from oligomannose and paucimannose structures
to exceptionally large complex N-glycans. Despite the presence
of the latter, no obvious homologues of known1–4-galactosyl-
transferase or 1–2- or 1–6-N-acetylglucosaminyltransferase
genes have been found in the parasite genome. However, we
previously reported a family of putative UDP-sugar-dependent
glycosyltransferases with similarity to the mammalian 1–3-
glycosyltransferase family. Here we characterize one of these
genes, TbGT11, and show that it encodes a Golgi apparatus res-
ident UDP-GlcNAc:3-D-mannoside 1–2-N-acetylglucosami-
nyltransferase I activity (TbGnTI). The bloodstream-form
TbGT11 null mutant exhibited significantly modified protein
N-glycans but normal growth in vitro and infectivity to rodents.
In contrast tomulticellular organisms, where the GnTI reaction
is essential forbiosynthesis of bothcomplexandhybridN-glycans,
T. brucei TbGT11nullmutants expressed atypical “pseudohybrid”
glycans, indicating thatTbGnTII activity is notdependentonprior
TbGnTI action. Using a functional in vitro assay, we showed that
TbGnTI transfers UDP-GlcNAc to biantennary Man3GlcNAc2,
but not to triantennaryMan5GlcNAc2, which is the preferred sub-
strate formetazoanGnTIs. Sequence alignment reveals that theT.
brucei enzyme is far removed from themetazoanGnTI family and
suggests that the parasite has adapted the 3-glycosyltransferase
family to catalyze1–2 linkages.
African trypanosomes are tsetse fly-transmitted protozoan
parasites that cause human African sleeping sickness and
nagana in livestock. Trypanosoma brucei undergoes a complex
life cycle, adapting to a bloodstream form in the mammalian
host, where it lives and divides extracellularly in the blood,
lymph, and interstitial fluids. A densely packed layer of glyco-
sylphosphatidylinositol (GPI)6-anchored variant surface glyco-
protein (VSG) covers the parasite cell surface (1). Apart from
serving as a physical barrier to components of the host comple-
ment system, this VSG coat undergoes antigenic variation that
allows the parasite to persist in the host bloodstream (2, 3). The
cell line used in this study (strain 427) expressesVSG221, which
contains a galactosylated GPI anchor (4) and two types of N-
glycans; triantennary oligomannose structures (Man7–9GlcNAc2)
at Asn-428 and biantennary paucimannose (Man3–4GlcNAc2)
and small complex (Gal0–2GlcNAc1–2Man3GlcNAc2) struc-
tures at Asn-296 (5).
N-Glycan biosynthesis takes place in the endoplasmic retic-
ulum (ER) andGolgi apparatus as a non-template assembly line.
The precursor forN-glycans is built on the lipid carrier dolichol
pyrophosphate (Dol-PP) in the ER membrane and, in higher
eukaryotes, ends in the formation of Glc3Man9GlcNAc2-PP-
Dol. The action of an oligosaccharyltransferase transfers the
glycan portion en bloc to the nascent glycoproteins. Subsequent
processing reactions trim Glc3Man9GlcNAc2 down to a trian-
tennary Man5GlcNAc2 structure (6). The first step in hybrid
and complex N-glycan biosynthesis is initiated by N-acetylglu-
cosaminyltransferase I (GnTI) through the addition of an
N-acetylglucosamine (GlcNAc) residue to the 1-3-linked core
mannose of Man5GlcNAc2. In multicellular organisms, the
GnTI reaction generally precedes the subsequent trimming
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reactions by Golgi -mannosidase II (7, 8) and is a prerequisite
for GlcNAc transfer to the 1-6-linked Man of GlcNAcMan3-
GlcNAc2 byN-acetylglucosaminyltransferase II (GnTII) (9, 10).
The absence of GnTI (and therefore a complete deficiency of
complex N-glycans) has been shown to be embryonic lethal in
mice (11, 12).
In contrast, T. brucei expresses two oligosaccharyltrans-
ferases with different substrate and acceptor specificities, one
(TbSTT3A) that transfers biantennary Man5GlcNAc2 to rela-
tively acidic glycosylation sites (e.g. Asn-263 of VSG221) and
another (TbSTT3B) that transfers Man9GlcNAc2 to any re-
maining sites (e.g. Asn-428 of VSG221) (13–16). It is proposed
that for the generation of complex N-glycans in T. brucei,
Man5GlcNAc2 is processed down to Man3GlcNAc2 and that
this serves as a substrate for both T. brucei TbGnTI and
TbGnTII. Thus, the actions of these two enzymes are suggested
to be independent of each other, which would imply that the
GlcNAc transferases involved in complex N-glycan biosynthe-
sis in T. bruceimay be different from their metazoan counter-
parts (15–18). Indeed, no obvious GnTI or GnTII homologs
have been identified in the parasite genome (19) and, so far, only
GPI anchor (20, 21) and unspecifiedGlcNAc transferase activities
(22, 23) have been detected using T. brucei cell-free systems.
Aminimum of 38 distinct glycosidic linkages have been identi-
fied in the T. brucei glycome (19), however, so far only six glyco-
syltransferases have been experimentally related to specific genes:
UDP-Glc:glycoprotein 1-3-glycosyltransferase to TbUGGT (24),
dolichol phosphate mannose synthase to TbDPMS (25), Dol-
P-Man:Man5GlcNAc2 1–3-mannosyltransferase to TbALG3
(16), Dol-P-Man:Man7GlcNAc2 1–6-mannosyltransferase to
TbALG12 (17, 18), Dol-P-Man:Man2GlcNPI 1-2-mannosyl-
transferase to TbGPI10 (26), and UDP-GlcNAc:-D-Gal-GPI
1-3-GlcNAc transferase to TbGT8 (19). In addition to these,
another seven TbGT genes can be reasonably confidently
assigned by sequence homology (i.e. TbALG1, -2, -7, -9, and -11
and TbGPI14 and -18). However, that still leaves a minimum of
25 glycosidic linkages looking for requisite GT genes. Intrigu-
ingly, searches of the T. brucei genome using a human 1-3-N-
acetylglucosaminyltransferase sequence (3GnT5) as the query
revealed 21 full-length ORFs encoding putative UDP-Gal or
UDP-GlcNAc-dependent GTs, only one of which (TbGT8) has
been characterized to date (19).
In the present study, we analyzed another of these putative
UDP-sugar-dependent GTs by a reverse genetics approach and
by in vitro functional activity assay. Our study revealed that the
gene TbGT11 (Tb427.3.5660) encodes a UDP-GlcNAc:3-D-
mannoside 1-2-N-acetylglycosaminyltransferase I activity
(EC 2.4.1.101) involved in the biosynthesis of complex N-gly-
cans and revealed significant differences between the parasite
enzyme and its metazoan counterparts both in amino acid
sequence and substrate specificity.
EXPERIMENTAL PROCEDURES
Cultivation of Trypanosomes—T. brucei brucei strain 427
bloodstream-form parasites, expressing VSG variant 221 and
transformed to stably express T7 polymerase and the tetracy-
cline repressor protein under G418 antibiotic selection (27),
were used in this study. This genetic background will be
referred to hereon as wild-type (WT). Cells were cultivated in
HMI-9 medium containing 2.5 g/ml of G418 at 37 °C in a 5%
CO2 incubator as described in Ref. 27.
DNA and RNA Isolation and Manipulation—Plasmid DNA
was purified from Escherichia coli (-select chemically compe-
tent cells, Bioline, London, UK) using Qiagen Miniprep or
Maxiprep kits, as appropriate. Gel extraction and reaction
cleanup was performed using Qiaquick kits (Qiagen). Custom
oligonucleotides were obtained from Eurofins MWG Operon
or the Dundee University oligonucleotide facility. T. brucei
genomic DNA was isolated from 2  108 bloodstream-form
cells using DNAzol (Helena Biosciences, UK) using standard
methods. T. brucei mRNA was extracted from 1  107 cells
using RNeasy RNA extraction kit (Qiagen).
Generation of Gene Replacement Constructs—The 554-bp 5
and 584-bp 3 UTR sequences next to the Tb427.3.5660 ORF
were PCR amplified from genomic DNA using Pfu DNA
polymerase with primers 5-atatgtttGCGGCCGCgtgataatgttc-
atgcaatg-3 and 5-gtttaaacttacggaccgtcaagctttggatgggtattaca-
aaaac-3, 5-gacggtccgtaagtttaaacggatcccttaagtgcaacaataac-
ttt-3 and 5-tctgGTCGACgtagtgaacaaactgttagc-3 as forward
and reverse primers, respectively. The two PCR products were
used together in a further PCR to yield a product containing the
5-UTR linked to the 3-UTR by a short HindIII, PmeI, and
BamHI cloning site (underlined) and NotI and SalI restriction
sites at the 5 and 3 end, respectively (capital letters). The pro-
duct was cloned into the NotI site of the pGEM-5Zf() vector
(Promega). An extra endogenous HindIII site identified in the
5-UTR (AAGCTT) was replaced by (AAGTTT) using Quik-
Change Site-directedMutagenesisKits (Stratagene) according to
the manufacturer’s instruction with primers 5-CCTTTT-
CTGTTCTATAGTTAAGTTTCATTGATAATCTAAACA-
AAC-3 and 5-CAAACAAATCTAATAGTTACTTTGAA-
TTGATATCTTGTCTTTTCC-3 as forward and reverse
primers, respectively.
The hygromycin phosphotransferase (HYG) and puromycin
acetyltransferase (PAC) drug-resistance genes were then
introduced into the targeting vector via the HindIII and BamHI
cloning sites. For re-expression of Tb427.3.5660 the ORF was
PCR-amplified from genomic DNA with the primer pair 5-
gctGGATCCtatggttattcgctctcccg-3 and 5-aacCTCGAGaacg-
tagctatggggtgacg-3 and cloned into pLEW100-Phleo (27).
For overexpression of full-length TbGT11 with a C-terminal
HA3 epitope tag, a plasmidwas generated based on the trypano-
some expression vector pLEW82 (27).TbGT11ORFwas ampli-
fied from T. brucei genomic DNA and primers 5-GACTAAG-
CTTATGGCAATCAAATCACGAGGAG-3 and 5-GACTT-
TAATTAAtgcgtaatcagggacgtcataaggatatgcgtaatcagggacgtcat-
aaggatacgctcccgcTGCCGTCCATTCCGCATCC-3 conta-
ining a HindIII and PacI restriction site (underlined), respec-
tively. The sequence encoding for twoHA tags (italics) followed
by a sequence encoding an Ala-Gly-Ala linker was attached as a
5 overhang of the reverse primer. The PCR product was subc-
loned into pLEW82-GPIdeAc-HA (28) viaHindIII and PacI res-
triction sites under replacement of the GPIdeAc insert, but re-
tention of the sequence encoding for one HA tag, resulted in
plasmid pLEW82-TbGT11-HA3. The identity of all constructs
was confirmed by sequencing.
T. brucei N-Acetylglucosaminyltransferase I
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Transformation of Bloodstream-form T. brucei—Constructs
for gene replacement and ectopic expression were purified,
digested with NotI to linearize, precipitated, washed with 70%
ethanol, and re-dissolved in sterile water. The linearized DNA
was electroporated into T. brucei bloodstream-form cells
(strain 427, variant 221) thatwere stably transformed to express
T7 RNA polymerase and the tetracycline repressor protein
under G418 selection. Cell culture and transformation were
carried out as described previously (27–29).
Southern Blotting—Aliquots of genomic DNA isolated from
100ml of bloodstream-form T. brucei cultures (2 108 cells)
were digested with ApaI, resolved on a 0.8% agarose gel and
transferred onto a Hybond-N positively charged membrane
(GE Healthcare, Amersham Biosciences). Highly-sensitive
DNA probes labeled with digoxigenin-dUTP were generated
using the PCR DIG Probe Synthesis Kit (Roche Applied Sci-
ence) according to the manufacturer’s recommendations and
hybridized overnight at 42 °C. Detection was performed using
alkaline phosphatase-conjugated anti-digoxigenin Fab frag-
ments and the chemiluminescent substrate CSPD (Roche).
Mouse Infectivity Studies—Wild-type and TbGT11 null mu-
tant bloodstream-form trypanosomes were grown in HMI-9T
media, washed inmedia without antibiotics and resuspended at
1 106 cells/ml. Groups of 5 female Balb/c mice were used for
each cell line and 0.1 ml of the suspension above was injected
intraperitoneally per animal. Infections were assessed daily by
tail bleeding and cell counting using a Neubauer chamber in a
phase-contrast microscope.
Semi-quantitative RT-PCR—To assess the amount of Tb427.
3.5660 mRNA in the TbGT11 conditional null mutant cells
grown under permissive and non-permissive conditions, RT-
PCRs were performed using the AccessQuick RT-PCR System
(Promega) according to the manufacturer’s recommendations.
A TbGT11 1074-bp fragment was amplified with the primer
pair 5-cgtttccaccaaaattccc-3 and 5-ttatgccgtccattccgcatc-3.
As a control of a similar RNA levels in both samples, primers
5-aatggatgcggaccttcagcacccac-3 and 5-tagaaccgtgagcgcggtg-
ccatac-3 amplifying a 448-bp product of dolichol phosphate
mannose synthase (Tb10.70.2610) were used.
Small Scale sVSG Isolation—Soluble-form VSG (sVSG) was
isolated from 100 ml of cultures containing 2  108 blood-
stream-formT. brucei by amodification of themethod of Cross
(30, 31) as described in Ref. 17. Briefly, cells were chilled on ice,
centrifuged at 2500  g for 10 min, and washed in an isotonic
buffer. The pellet was resuspended in 300 l of lysis buffer (10
mM NaH2PO4 buffer, pH 8.0, containing 0.1 mM tosyllysine
chloromethyl ketone hydrochloride (TLCK), 1 g/ml of leu-
peptin, and 1 g/ml of aprotinin) and incubated for 5 min at
37 °C. The sample was centrifuged at 14,000 g for 5 min, and
the supernatant was applied to a 200-l DE52 anion exchange
column pre-equilibrated in 10 mM sodium phosphate buffer,
pH 8.0. Elution was performed with 0.8 ml of 10 mM sodium
phosphate buffer, pH 8.0, the eluate was concentrated and dia-
filtered with water on a YM-10 spin concentrator (Microcon).
The final sample of 50–100 g of sVSG221 was recovered in a
volume of 100 l of water.
ES-MS Analysis of Intact sVSG—50-g Aliquots of sVSG
preparations were diluted to0.05 g/l in 50%methanol, 1%
formic acid and analyzed by positive ion ES-MS on a Q-TOF
6520 instrument (Agilent). Data were collected, averaged, and
processed using the maximum entropy algorithm of the Mass-
Hunter software (Agilent).
Purification and MALDI-TOF Analysis of VSG GPI An-
chors—Aliquots of purified sVSGs were treated with 50 l of
ice-cold 50% aqueous hydrogen fluoride for 48 h at 0 °C to
cleave the GPI anchor ethanolamine-phosphate bond. The
resultant GPI glycans were dried, re-dissolved in 50l of water,
and transferred into a 2-ml Reactivial (Pierce). Samples were
dried and then re-dried from 50 l of methanol, followed by
permethylation as described previously (32). Finally, permethy-
lated glycans were mixed with 2,5-dihydroxybenzoic acid
matrix and analyzed in positive-ionmodeusing anABIVoyager
DE-STR MALDI-TOF mass spectrometer.
ES-MS/MS Analysis of Pronase Glycopeptides—50-g Ali-
quots of sVSG preparations weremixed with 5l of 1 M ammo-
nium bicarbonate buffer and 10 l of 1 mg/ml of freshly pre-
pared Pronase (Sigma) dissolved in 5 mM calcium acetate and
incubated for 48 h at 37 °C. In some experiments, the parasites
were grown for 72 h in the presence of a mixture of -manno-
sidase inhibitors (0.8 mM 1-deoxymannojirimycin (R&D Sys-
tems, Inc., Minneapolis, MN), 186 M kifunensine (Santa Cruz
Biotechnology, Dallas, TX), and 100 M swainsonine (Sigma))
before sVSG isolation. The Pronase glycopeptides were puri-
fied using Envicarb graphitized carbon microcolumns as
described previously (16, 33). Aliquots of these enriched glycan
samples were loaded into nanotips (Waters-type F) and ana-
lyzed by ES-MS and ES-MS/MS in positive-ion mode on an
LTQOrbitrap XL mass spectrometer (Thermo Scientific) with
tip and 1100 V. The product ion spectra of selected ions were
collected using collision energies of 8–20V.TheES-MS spectra
were processed using the Thermo Xcalibur software.
Analysis of Total N-Glycans by Lectin Blotting and LC-
MS—To analyze the totalN-glycan fraction of T. brucei blood-
stream-form cells,2 109 cells were first depleted of VSG by
hypotonic lysis (30, 31). ForWestern blot analysis, residual cell
ghosts were solubilized in a SDS sample buffer containing 8 M
urea, boiled with DTT, separated by SDS-PAGE (approxi-
mately 1  107 cell equivalents/lane) on NuPAGE bis-Tris
4–12% gradient acrylamide gels (Invitrogen), and transferred
to nitrocellulose membrane (Invitrogen). Ponceau S staining
confirmed equal loading and transfer. Glycoproteins were
probed with 1.7 g/ml of biotin-conjugated ricin (RCA-120,
Vector Laboratories, Peterborough, UK) in PBS before or after
preincubation with 10 mg/ml of D-galactose and 10 mg/ml of
-lactose to confirm specific ricin binding. Detection was per-
formed using IRDye 680LT-conjugated streptavidin and the LI-
COR Odyssey Infrared Imaging System (LICOR Biosciences,
Lincoln, NE). For mass spectrometry analysis, glycans were
purified by modification of the filter-aided sample preparation
procedure (34). Briefly, cell ghostswere solubilized in 1ml of 8%
SDS, 200 mM DTT, 200 mM Tris-HCl, pH 8.0, per 1 109 cell
equivalents by vigorous vortexing for 3 min, sonication for 3
min, heating to 95 °C for 3 min, and a further 3-min vortexing
step. After clearing the lysate by centrifugation at 16,000 g for
5 min, the solubilized sample was reductively alkylated in a
30,000 molecular weight cutoff spin filtration unit (Sartorius
T. brucei N-Acetylglucosaminyltransferase I
9330 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 13•MARCH 28, 2014
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on February 24, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
AG, Goettingen, Germany) using the filter-aided sample prep-
aration procedure II procedure adapted for larger volumes.
Digest with 25 g/ml of trypsin gold (Promega) was performed
in the filtration unit overnight at 37 °C and peptideswere eluted
by centrifugation, whereas the bulkier glycopeptides remained
in the retentate. Residual trypsin in the filter was inactivated by
50 g/ml of trypsin inhibitor from bovine pancreas (Sigma),
followed by two wash steps with 50 mM NH4HCO3. Glycopep-
tides were transferred into a microcentrifuge tube and incu-
bated with 4 units of peptide:N-glycosidase F (Roche Applied
Science) overnight at 37 °C. Finally, released glycans were
desalted on a mixed-bed ion exchange column of 100 l of
Chelex-100 (Na) over 100l of AG50X12 (H), over 200l of
AG3X4 (OH), and over 100l ofQAE-Sephadex25 (OH), all
from Bio-Rad Laboratories, except QAE-Sephadex (Sigma).
After freeze-drying, glycans were permethylated as described
previously (32) and dissolved in 10%methanol, 1% formic acid.
Analysis was performed by LC-MS using a C18 reversed-phase
column (Acclaim RSLC PepMap, 75 m  15 cm, Thermo
Scientific) and a 10–90% acetonitrile gradient with a LTQ
Orbitrap XL mass spectrometer (Thermo Scientific). All runs
were done at a flow-rate of 0.3 l/min and a column tempera-
ture of 30 °C. Extracted ion chromatograms were created using
the Thermo Xcalibur software.
GnTI in Vitro Activity Assay—TbGT11 fused to a C-terminal
triple HA tag was overexpressed inT. brucei bloodstream-form
cells. 1 109 cells were lysed on ice in 25 mM Tris, pH 7.5, 100
mM NaCl, 1% Triton X-100 containing a mixture of protease
inhibitors (CompleteMini, Roche) and 0.1 mM TLCK. Expres-
sion was confirmed by SDS-PAGE and Western blotting.
Briefly, 5  106 cell equivalents/lane were separated on
NuPAGE bis-Tris 4–12% gradient acrylamide gels (Invitrogen)
and transferred to nitrocellulose membrane (Invitrogen). Pon-
ceau S staining confirmed equal loading and transfer. Detection
was performed using 0.5 g/ml of rabbit anti-HA antibody
(QED Bioscience Inc., San Diego, CA) and IRDye 680LT-con-
jugated donkey anti-rabbit IgG and the LI-COR Odyssey
Infrared Imaging System (LICOR Biosciences). For the in vitro
activity assay, TbGT11-HA3 was immunoprecipitated using
anti-HA bead magnetic beads (Pierce) and incubated with 1
Ci of UDP-[3H]GlcNAc (specific activity of 20–40 Ci/mmol,
PerkinElmer Life Sciences), 1mM coldUDP-GlcNAc (Sigma), 5
g of oligomannose-3 (a), or 5 g of oligomannose-5 (Dextra
Laboratories, Reading, UK) in 50 mM Tris, pH 7.5, 10 mM
MgCl2, 10mMMnCl2 in a total volume of 50l. After overnight
incubation under vigorous shaking at room temperature,
samples were desalted via a mixed-bed ion exchange column
as described above, freeze-dried, and re-dissolved in 20%
1-propanol. Aliquots were spotted onto silica HPTLC plates
(SI-60 HPTLC, Millipore) that were run twice in 1-propanol/
acetone/H2O (9:6:4). For product analysis, samples were
treated with1–2,3-mannosidase fromXanthomonasmaniho-
tis (NewEnglandBiolabs) beforeTLC analysis. Plateswere then
dried, sprayed with EN3HANCE autofluorography enhancer
(EN3HANCE, PerkinElmer Life Sciences), and exposed on
x-ray film at80 °C for 1–2 days.
Immunofluorescence Analysis—Bloodstream-form cells trans-
formed with pLEW82-TbGT11HA3 for overexpression of
TbGT11 fused to a C-terminal triple HA tag were fixed with 4%
paraformaldehyde and permeabilized with 0.1% Triton X-100.
Cells were co-stained with 0.3 g/ml of mouse anti-HA anti-
body (kind gift of Dario Alessi, University of Dundee, UK) and
rabbit anti-enolase serum (1:2000, kindly provided by Paul
Michels, Catholic University of Louvain, Belgium), rabbit anti-
BiP serum (1:2000, kind gift of Jay Bangs, University ofWiscon-
sin-Madison, WI), rabbit polyclonal anti-trypanopain (1:300,
kind gift of Jay Bangs, University of Wisconsin-Madison), or
anti-Golgi reassembly stacking protein antisera (1:500, kindly
provided byGrahamWarren,MFPL,Austria) followed by incu-
bation with Alexa Fluor 594-conjugated goat anti-mouse IgG
andAlexa Fluor 488-conjugated goat anti-rabbit IgG secondary
antibodies (Invitrogen). Coverslips were mounted in ProLong
Gold mounting medium containing DAPI (Invitrogen) and
imaged under a Delta Vision Core deconvolution microscope
(Applied Precision, Inc.).
RESULTS
Analysis of the TbGT11 Gene Product—A family of 21 genes
encoding putative UDP-sugar-dependent GTs was previously
found in the T. brucei genome (19). In the current study, one of
these genes (Tb927.3.5660) was selected for functional analysis.
It encodes for a 388-amino acid protein with a theoretical
molecular mass of 49.5 kDa. Although a semi-quantitative RT-
PCR analysis suggested that this gene is expressed in similar
levels in both bloodstream and procyclic form parasites (19),
SILAC-based quantitative proteomics data demonstrated that
at the protein level, the expression is more than 40 times higher
in the bloodstream form (35).
When analyzed by software for predicting transmembrane
helices based on a hidden Markov model (36), the protein is
predicted to be a type II transmembrane protein, a hallmark of
Golgi apparatus glycosyltransferases (37). Proximal to the pre-
dicted transmembrane domain, the N-terminal cytoplasmic
tail contains a dibasicmotif, which functions as anER exit signal
in known Golgi resident glycosyltransferases (38). Moreover,
the protein contains a DXD motif (39), another common fea-
ture found in glycosyltransferases, as well as three putative
N-glycosylation sites.
TheT. brucei strain that was used for the genome sequencing
project (TREU929) is different from the one that was used in
this study (Lister strain 427). Alignment ofTb927.3.5660 and its
homologue Tb427.3.5660 revealed a very high similarity with
only 8 single nucleotide polymorphisms. Two of them results in
amino acid changes (strain 427 encodes for Leu-175 in place of
Ile-175 and Val-347 instead of Met-347). The strain 427 gene
and protein product will be referred to here as TbGT11 and
TbGT11, respectively.
Creation of Bloodstream-formTbGT11Null andConditional
Null Mutants—Blast search of the T. brucei genome indicated
that TbGT11 is present as a single copy per haploid genome.
Both alleles were replaced sequentially in the bloodstream-
form parasite with PAC and HYG drug resistance cassettes by
homologous recombination as summarized in Fig. 1A. Clones
were selected on the relevant antibiotics and the generation of a
TbGT11 null mutant (TbGT11::PAC/TbGT11::HYG) was
confirmed by Southern blot (Fig. 1B). A tetracycline-inducible
T. brucei N-Acetylglucosaminyltransferase I
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ectopic copy of the TbGT11 gene was introduced into the
rDNA locus of a null mutant clone using the pLEW100 vector
(27) and phleomycin selection (Fig. 1A, in brackets). The gener-
ation of this conditional null mutant (TbGT11Ti/TbGT11::
PAC/TbGT11::HYG) was confirmed by RT-PCR (Fig. 1C).
The mutant cell lines had no noticeable differences in gross
morphology, as judged by light microscopy (data not shown).
Moreover, the in vitro growth rates of the TbGT11 null mutant
and its ability to infect mice were indistinguishable from their
parental cell line (Fig. 2). From these data we conclude that
TbGT11 encodes a non-essential gene in T. brucei blood-
stream-form cells.
Characterization of VSG fromWTand TbGT11NullMutant
Parasites—To perform glycosylation phenotyping of blood-
stream-form TbGT11 null mutants, VSG221 was purified in
its soluble form. The VSG coat is released upon cell lysis by the
action of endogenous GPI-specific phospholipase C (40). Intact
sVSG glycoproteins from WT and mutant cells were analyzed
by positive-ion ES-MS and the deconvolved mass spectra are
depicted in Fig. 3. The typical glycoform pattern of wild-type
sVSG221 (Fig. 3A) arises from its highly galactosylated GPI
anchor (4) and its two N-glycans; triantennary oligomannose
structures at Asn-428 (Man5-Man9GlcNAc2) and small bian-
tennary structures ranging fromMan3GlcNAc2 to Gal2GlcNAc2-
Man3GlcNAc2 at Asn-296 (5).
Although VSG glycoforms containing a total of four or five
GlcNAc residues were present at similar levels in both geno-
types, glycoforms with six GlcNAc residues were noticeably
reduced in the TbGT11 null mutant (see arrows in Fig. 3B and
Table 1). Considering that the twoN-glycanN-acetylchitobiose
core structures account for four GlcNAc residues, this reduc-
tion in VSG glycoforms containing six GlcNAc residues sug-
gests a reduction in the proportion of biantennary complex
N-glycans. These data provided the first indication that the
mutant cells cannot express complex N-glycans and that
TbGT11 is involved in their biosynthesis.
VSG GPI anchor dephosphorylation with aqueous hydrogen
fluoride followed by permethylation andMALDI-TOF analysis
showed no changes in the structure of the GPI anchor side
FIGURE 1. Generation of a bloodstream-form TbGT11 null and condi-
tional mutant. A, gene replacement strategy to create TbGT11 null
mutant cells and subsequent insertion of tetracycline-inducible ectopic
copy, in brackets, to create a conditional null mutant. B, Southern blot of
genomic DNA digested with ApaI from WT (lanes 1, 3, and 5) and TbGT11
null mutant cells (lanes 2, 4, and 6). The blot was probedwith a TbGT11ORF
probe (left hand panel) and a TbGT11 3 UTR probe (middle panel) and
indicates the replacement of both alleles with drug resistance cassettes.
Equal loading was verified by ethidium bromide staining (right hand
panel). C, ethidium bromide-stained agarose gel of reverse transcription-
PCR products from RNA extracted from WT cells (lane 1) and TbGT11 con-
ditional null mutants grown under permissive (lane 2) or non-permissive
conditions (lane 3). The upper panel shows RT-PCR products using primers
for TbGT11, the middle panel is a control using dolicholphosphate man-
nose synthase (DPMS) primers to show equal RNA input, and the lower
panel is a control without reverse transcriptase.
FIGURE 2. A, growth phenotypes of WT and TbGT11 mutant cells. Cells were
inoculated into culture, counted, and diluted to 1  104 cells/ml with fresh
media every 2 days. The growth characteristics for WT (black triangles),
TbGT11 conditional null cells under permissive (plus tetracycline, gray dia-
monds) and non-permissive (minus tetracycline, gray squares) conditions
were indistinguishable. B, infectivity of WT and TbGT11 null mutant blood-
stream-form parasites to mice. Mice were infected with 1  105 cells of WT
(black) or TbGT11 null mutants (gray) and parasite cell numbers were deter-
mined after 1, 2, and 3 days. No difference in infectivity was observed
between WT and TbGT11 null mutant cells.
T. brucei N-Acetylglucosaminyltransferase I
9332 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 13•MARCH 28, 2014
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on February 24, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
chain (Fig. 4). This result shows that the intact VSG glycoform
changes observed in Fig. 3 are due solely to changes inN-glycan
structure.
N-Glycosylation Phenotype of Bloodstream-form TbGT11
Mutant Parasites—To detect changes in the glycosylation of
proteins other than VSG, total glycoproteins were extracted
with SDS/urea from VSG-depleted trypanosome ghosts and
analyzed by lectin blotting. As previously reported for WT T.
brucei (19, 41), ricin (RCA-120), a lectin that predominantly
binds to terminal -galactose residues, showed strong binding
to a series of glycoproteins running between 60 and 150 kDa
(Fig. 5, lane 1). In contrast, ricin binding to glycoproteins
FIGURE 3. Mass spectrometric analysis of intact sVSG221 from WT and
TbGT11 null mutant trypanosomes. Samples of whole sVSG of WT (A) or
TbGT11 null mutant cells (B) were analyzed by ES-MS, and the spectra were
deconvolvedbymaximumentropy. Significant differences in the sVSGglyco-
form patterns are indicated by arrows in panel B. The compositions of the
various glycoforms are given in Table 1.
FIGURE 4. MALDI-TOF mass spectra of permethylated GPI anchors iso-
lated fromWT and TbGT11 null mutant sVSGs. Permethylated GPI glycans
of WT (A) or TbGT11 null mutant (B) sVSGs were analyzed by MALDI-TOF MS.
The annotated ions correspond to the permethylated GPI glycan core of
Man3GlcNMe3-inositol with 3–6 side chain Gal residues, as indicated,
together with theirm/z values.
TABLE 1
Isobaric glycoforms of sVSG221 identified by ES-MS
The molecular weights of different glycoforms of sVSG221 were calculated according to the indicated compositions (in parentheses is the theoretical mass of the assigned
VSG composition). The relative abundances of those glycoforms observed in Fig. 3 for sVSG preparations fromWT cells and TbGT11 null mutant cells are indicated by:
, trace,,, and scores.
Molecular mass WT/TbGT11
null mutant (theoretical) Proteina GlcN-Ino-cPb EtNP GlcNAc Man Gal WT
TbGT11 null
mutant
Da
50364/50364 (50356) 1 1 1 4 17 c Traces
50404/50404 (50397) 1 1 1 5 16 Traces Traces
50525/50526 (50518) 1 1 1 4 18  
50566/50567 (50559) 1 1 1 5 17 Traces Traces
50607/NA (50600) 1 1 1 6 16 Traces 
50687/50688 (50680) 1 1 1 4 19  
50730/50731 (50721) 1 1 1 5 18  Traces
50850/50850 (50842)d 1 1 1 4 20  
50891/50894 (50883) 1 1 1 5 19  
50933/NA (50924) 1 1 1 6 18 Traces 
51012/51012 (51004) 1 1 1 4 21  
51053/51053 (51045) 1 1 1 5 20  
51096/51103 (51086) 1 1 1 6 19  Traces
51174/51174 (51166) 1 1 1 4 22  
51215/51215 (51207) 1 1 1 5 21  
51257/51261 (51248) 1 1 1 6 20  Traces
51337/51337 (51328) 1 1 1 4 23  
51377/51377 (51369) 1 1 1 5 22  
51419/51420 (51410) 1 1 1 6 21  Traces
51499/51499 (51490) 1 1 1 4 24  
51540/51540 (51531) 1 1 1 5 23  
51580/NA (51572) 1 1 1 6 22  
51662/51661 (51652) 1 1 1 4 25  
51703/51702 (51693) 1 1 1 5 24  Traces
51743/NA (51734) 1 1 1 6 23 Traces 
a ProteinMr is based on the amino acid sequences of the VSG221 precursor (accession no. P26332) minus residues 1–27 (signal peptide) and 460–476 (GPI attachment sig-
nal peptide) and allows for four disulfide bonds (Mr 46,284).
b Components specific to the GPI anchor and common to all glycoforms: GlcN-Ino-cP, glucosamine-1–6-myo-inositol-1,2 cyclic phosphate; EtNP, ethanolamine
phosphate.
cMaximum entropy deconvolved spectra are only semi-quantitative; an indication of the relative abundance of the isobaric glycoforms is given based on peak
height.
d The most abundant glycoform of WT sVSG221 is expected to contain a GPI anchor of composition of Man3Gal5, a C-terminal N-linked glycan of Man9GlcNAc2, and an
internal N-linked glycan of Man3GlcNAc2 (i.e. GlcNAc 4, and Man 20).
T. brucei N-Acetylglucosaminyltransferase I
MARCH 28, 2014•VOLUME 289•NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 9333
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on February 24, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
extracted from the TbGT11 conditional null mutants grown
under non-permissive conditions was greatly reduced (Fig. 5,
lane 3), indicating that TbGT11 might be play a role in the
formation of hybrid and/or complexN-glycans. The phenotype
was fully reversed in conditional nullmutants grownunder per-
missive conditions (in the presence of tetracycline) (Fig. 5, lane
2), confirming that the observed glycosylation defects are spe-
cifically due to the loss of TbGT11 expression.
To further advance the glycosylation phenotyping, the total
N-glycan fraction from VSG-depleted cell ghosts was purified,
permethylated, and analyzed by LC-MS. As shown in Fig. 6,
extracted ion chromatograms revealed significant differences
in theN-glycan pattern ofWT (upper panel) and TbGT11 con-
ditional null mutant parasites grown under permissive condi-
tions (middle panel) compared with TbGT11 conditional null
FIGURE 5. Lectin blotting of total glycoproteins.Western blot of total gly-
coproteins (depleted for VSG) ofWT (lanes 1, 4, and 7), TbGT11 conditional null
mutants grown under permissive conditions (lanes 2, 5, and 8) and TbGT11
conditional null mutants grown under non-permissive conditions (lanes 3, 6,
and 9) incubated with ricin (left-hand panel). Binding specificity was con-
firmed by preincubating the lectin with 10 mg/ml of galactose and lactose
(middle panel). Ponceau S staining shows equal loading and transfer between
the lanes (right-hand panel).
FIGURE 6. Extracted ion chromatograms from LC-MS analysis of total N-glycans. Total N-glycans of WT and TbGT11 conditional null mutant cells grown
under permissive or non-permissive conditions were enriched, permethylated, and analyzed by LC-MS. Shown are the extracted ion chromatograms of
Hex3HexNAc2 (A), Hex3HexNAc3 (B), Hex4HexNAc4 (C), Hex5HexNAc4 (D), Hex6HexNAc4 (E), and Hex7HexNAc4 (F). In each box, the upper panel shows the
chromatogram fromWT cells, themiddle panel represents the chromatogram from TbGT11 conditional null mutant cells grown under permissive conditions,
and the lower panel results from TbGT11 conditional null mutant cells grown under non-permissive conditions.
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mutant parasites grown under non-permissive conditions
(lower panel). Thus, whereas all three samples contain the con-
ventional biantennary Man1-3(Man1-6)Man1-4GlcNAc1-
4GlcNAc(Hex3HexNAc2) core as well as said structure
extended by an additional GlcNAc residue (Hex3HexNAc3)
(Fig. 6A, B), complex glycans with two GlcNAc residues
attached to both 3- and 6-Man arms, i.e. GlcNAc1-
2Man1-3(GlcNAc1-2Man1-6)Man1-4GlcNAc1-4GlcNAc
and further elongated structures, were easily detected inWT cells
and theTbGT11 conditional nullmutant grownunder permissive
conditions but absent in the TbGT11 null mutant grown under
non-permissive conditions (Fig. 6,C–F). These data strongly sug-
gest that TbGT11 has UDP-GlcNAc:glycoprotein GlcNAc trans-
ferase activity and is required for formation of biantennary com-
plexN-glycans.
Analysis of VSG Pronase Glycopeptides of TbGT11 Null
Mutant Cells Grown in the Presence and Absence of -Manno-
sidase Inhibitors—Although the data described so far demon-
strate that TbGT11 is responsible for GlcNAc transfer to the
Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc core, they
contain no information as to whether the transfer is to the 3- or
6-arm. To answer this question,TbGT11 nullmutant cells were
incubated with a mixture of cell-permeable -mannosidase
inhibitors (kifunensine, swainsonine, and 1-deoxymannojiri-
mycin) for 72 h to inhibitT. bruceiERandGolgi-mannosidase
activity (15, 16). Extracted sVSGs from TbGT11 null mutant
cells treated with or without -mannosidase inhibitors, as well
as fromWT cells, were then digested with Pronase. The result-
ing glycopeptides were enriched on graphitized carbon before
analysis by ES-MS in a positive-ion mode. The identities of the
FIGURE 7. ES-MS analysis of PronaseN-glycopeptides andGPI peptides. Aliquots of sVSG221were digestedwith Pronase and the resulting glycopeptides
were enriched and analyzed by ES-MS in positive-ion mode. The identities of the ions from WT (A), TbGT11 null mutant (B), and the TbGT11 null mutant cells
grown in the presence of -mannosidase inhibitors (C) are indicated and were confirmed by MS/MS (data not shown). The N-linked glycopeptides appear
as multiple ions due to incomplete Pronase digestion, i.e. the Asn-263 site is found as RNE-, RNET-, RNETAG-containing glycopeptides, and the Asn-428 site is
found as NTT- and TNTT-containing glycopeptides.
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detected ions were assigned based on their accurate mass and
were confirmed by ES-MS/MS. TheWT spectrum showed the
typical range of known VSG glycopeptides (15, 16); i.e. small
biantennary paucimannose and complexN-glycans attached to
Asn-263 and triantennary oligomannose structures attached to
Asn-428, as well as GPI-peptides (Fig. 7A). The TbGT11 null
mutant VSG Pronase glycopeptide spectrum showed the
absence of complex N-glycan glycoforms, consistent with the
previous data (Fig. 7B). The inhibition of -mannosidase pro-
cessing resulted in the replacement of Man3GlcNAc2-based
structures by biantennary Man5GlcNAc2-based structures, as
expected (Fig. 7C). However, the most important feature is the
presence of the glycopeptide ions Hex5HexNAc3-RNE(TAG)
(at m/z 919.4, 969.9, and 1033.9, respectively), as it demon-
strates that biantennary Man5GlcNAc2 (Man1-2Man1-
2Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc) has been
extended by a GlcNAc residue, presumably to the 6-arm by
TbGnTII. Because this transfer to the 6-arm is clearly not influ-
enced by the deletion of TbGT11, the enzymatic function of
TbGT11 is most likely the transfer of 1–2-linked GlcNAc to
the 3-arm; i.e. that of a GnTI enzyme.
In Vitro Functional Activity Assay—To provide unambigu-
ous evidence that TbGT11 is a glycosyltransferase and not
simply required for the activity of another gene product, an in
vitro assay for enzymatic activity was performed. Full-length
TbGT11 fused to a C-terminal HA3 epitope tag was transfected
into bloodstream-form T. brucei using a pLEW82 vector (27)
and expression was confirmed byWestern blot detection with an
anti-HAantibody (Fig. 8A). Proteinwas immunoprecipitatedwith
anti-HA magnetic beads and incubated with Man1-3(Man1-
6)Man1-4GlcNAc1-4GlcNAc (oligomannose-3) or Man1-
2Man1-2Man1-3(Man1-6)Man1-4GlcNAc1-4GlcNAc
(oligomannose-5) as acceptor substrate and tritium-labeled
UDP-[3H]GlcNAc as donor substrate. Reaction products were
desalted and separated from unincorporated sugar nucleotides
by mixed-bed ion exchange. Aliquots were analyzed by thin-
layer chromatography (TLC) followed by autofluorography.
As seen in Fig. 8B, oligomannose-3, but not oligomannose-5, is
used as an acceptor substrate for TbGT11. No transfer was
observed in a negative control without TbGT11-HA3. This
clearly demonstrates that TbGT11 has glycosyltransferase
activity and is able to transfer GlcNAc to biantennary Man1-
3(Man1-6)Man1-4GlcNAc1-4GlcNAc core structures.
To determine whether GlcNAc is transferred to the 3- or
6-Man arms of oligomannose-3, tritium-labeled reaction prod-
ucts were treated with 1–2,3 mannosidase, a highly specific
exoglycosidase that catalyzes the hydrolysis of the 3-Man arm.
Samples were separated by TLC followed by fluorography. As
shown in Fig. 8C, Rf values of both samples were identical, con-
sistent with the transferred GlcNAc residue being attached to
the 3-Man arm and thereby impairing the cleavage by 1–3-
mannosidase. This is in agreement with our previous data on
the sVSG Pronase glycopeptides from -mannosidase-treated
TbGT11 null mutants (Fig. 7C). Taken together, our data pro-
vide evidence that TbGT11 is responsible for GlcNAc transfer
to the 1–3-linked D-mannopyranosyl residues of Man1-
3(Man1-6)Man1-4GlcNAc1-4GlcNAc.
TbGT11 Is Localized in the Golgi Apparatus—Subcellular
localization of HA-tagged TbGT11 was analyzed in T. brucei
bloodstream-form parasites by immunofluorescence micros-
copy. Co-localization studies using antibodies against cell com-
partment-specific marker proteins and anti-HA antibodies are
shown in Fig. 9. No staining of TbGT11 was detected in the
cytosol (Fig. 9,A–D), the ER (Fig. 9, E–H), or the lysosome (Fig.
9, I–L), using enolase (42), BiP (43), and trypanopain (44) as
markers, respectively. Instead, TbGT11 was clearly found to
co-localize with Golgi reassembly stacking protein (GRASP)
FIGURE 8. TbGT11-HA3 expression and in vitro activity assay. A, Trypanosome bloodstream-form cell lysates fromWT cells (lane 1) or cells transfected with
pLEW82-GT11-HA3 (lane 2) were separated by SDS-PAGE and analyzed byWestern blotting with a rabbit anti-HA antibody. B, TLC autofluorography of in vitro
reaction products. After incubation of TbGT11-HA3 attached to anti-HA-conjugated magnetic beads with UDP-[
3H]GlcNAc as well as the acceptor substrates
Man3GlcNAc2, Man5GlcNAc2, or no acceptor (H2O), reaction products were separated by TLC (lanes 1–3). As a negative control, anti-HA magnetic beads
incubatedwith lysates fromcells not expressing TbGT11-HA3wereused (lane 4-6).C, theobtained [
3H]GlcNAcMan3GlcNAc2 reactionproductwas separatedby
TLC before and after 1–2,3 mannosidase treatment and visualized by fluorography.
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(45) (Fig. 9, M–P), consistent with being a Golgi-resident
glycosyltransferase.
DISCUSSION
The canonicalmodification ofN-glycans byGnTI gene prod-
ucts to give rise to conventional complexN-glycan structures is
widely considered as a hallmark of multicellular organisms, as
both appeared in evolution at about the same time (46). Mam-
malian cell lines lacking a functional GnTI (Mgat1/) show
normal growth in culture but mouseMgat1-null mutants die at
embryonic day 10 with severe multisystemic developmental
abnormalities (11, 12). These developmental defects are con-
sistent with the known roles of complexN-glycans inmetazoan
intercellular communication and signaling. On the other hand,
T. brucei is a unicellular protozoan organism that also produces
both conventional biantennary complex N-glycans and unique
highly extended and branched poly-N-acetyllactosamine-con-
tainingN-glycan structures (5, 41, 47, 48). The precise role(s) of
these complex structures, present in the bloodstream formofT.
brucei, are less than clear. For example, poly-N-acetyllac-
tosamine structures have been suggested to be involved in
receptor-mediated endocytosis (49), but recent data on the gly-
cosylation of the trypanosome transferrin receptor has ques-
tioned this function (50). Furthermore, the origins of these
structures are also mysterious because canonical GnTI and
GnTII genes, encoding the1–2-GlcNAc transferases that nor-
mally initiate elaboration of the 3- and 6-arms, respectively, of
the common Man3GlcNAc2 core are not obviously present in
the T. brucei genome (19). In the present study TbGT11
(Tb427.3.5660), which was predicted to encode a putative
UDP-sugar dependent glycosyltransferase (19), has been shown
to encode a Golgi apparatus enzyme that performs a GnTI-like
function; i.e. the transfer of GlcNAc to the 3-arm of the
Man3GlcNA2 N-glycan core via a UDP-N-acetylglucosaminyl:
1–3-D-mannoside-1–2-N-acetylglucosaminyltransferase
activity. We have therefore renamed TbGT11 to TbGnTI.
A multiple sequence alignment of TbGnTI and GnTI pro-
teins of other species produced the phylogram shown in Fig. 10.
The GnTIs of multicellular organisms are closely related and
belong to the CAZy (carbohydrate-active enzymes) GT family
13 (51). The phylogram illustrates how divergent TbGnTI is
from the canonical GnTI family. TbGT11, along with 20 other
related T. brucei sequences, was identified by BLAST search
using a human 3GnT5 query, a member of the CAZy GT 31
family (19). The trypanosome proteins all contain three motifs
that are very similar to the (I/L)RXXWG, (F/Y)(V/L/M)XXX-
DXD, (ED)D(A/V)(Y/F)XGX(C/S) motifs conserved among
members of the 3-glycosyltransferase family (52). Thus,
whereas the only other characterized member of this trypano-
someGT family is a1–3-GlcNAc transferase (19), our present
study reveals that a member of the 3-glycosyltransferase
sequence family, TbGnTI, has 1–2-GlcNAc transferase activ-
ity. So far as we are aware, this is the first example of the repur-
posing of a 3-glycosyltransferase family member to catalyze
the formation of another kind of glycosidic linkage. This might
FIGURE 9. Golgi localization of TbGT11. Fixed and permeabilized blood-
stream-form parasites expressing TbGT11-HA3 were co-stained with anti-HA
antibodies to detect TbGT11 localization (red) and either anti-Enolase (A–D),
anti-BiP (E–H), anti-trypanopain (I–L), or anti-Golgi reassembly stacking pro-
tein (GRASP) (M–P) to detect the cytosol, ER, lysosome, or Golgi apparatus,
respectively (green). Cells were counterstained with DAPI (blue) to reveal
nuclei and kinetoplasts. Merged DAPI/DIC images are presented on the left
and merged three-channel fluorescence images are presented on the right.
Prominent co-localization is indicatedbyanarrowhead (P, yellow). No staining
of untransfected (non-epitope-tagged) cells was detected under the same
conditions with anti-HA antibodies (data not shown).
FIGURE 10. Phylogenetic tree of GnTI amino acid sequences from different species. Amino acid sequences were aligned using the COBALT constraint-
basedmultiple alignment program. GnTI:Homo sapiens (AAH03575.1),Macacamulatta (NP_001244759.1),Musmusculus (NP_001103620.1), Rattus norvegicus
(AAH74010.1), Bos taurus (AAI51368.1),Danio rerio (NP_956970.1), Caenorhabditis elegans (AAD03022.1),Drosophila melanogaster (NP_525117.2), Arabidopsis
thaliana (NP_849517.1), Oryza sativa (BAD28450.1). The length of the horizontal lines represents the evolutionary distance.
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indicate that, apart from TbUGGT (24), trypanosomes have
only one group of UDP-sugar-dependent GTs, evolved from a
common ancestor 3-glycosyltransferase, to catalyze the vari-
ety of different linkages present in its diverse glycoconjugate
repertoire (19). Consequently, the functional analysis of the
other TbGT familymembers is an intriguing task for the future.
We were able to overexpress TbGnTI and show, by direct
enzymatic assay, that whereas it recognizes Man3GlcNAc2, it
cannot act on triantennary Man5GlcNAc2, which is the pre-
ferred acceptor substrate for vertebrate GnTI activities (46).
This unusual specificity of TbGnTI is consistent with data pre-
sented in Refs. 16 and 17, which suggest that it is the presence of
the 1–6-linked mannose residue transferred by the ALG12
gene product in Man5GlcNAc2 that prevents TbGnTI from
being able to transfer GlcNAc to the 3-arm and, therefore,
makesT. brucei unable tomake conventional hybridN-glycans.
In addition, the N-glycan profiles reported here for TbGnTI
null mutant cells, grown with and without -mannosidase
inhibitors, demonstrate that the transfer of GlcNAc to the
6-arm of the trimannosyl core is completely unaffected by the
status of the 3-arm, which can be unsubstituted or substituted
withmannobiose. The synthesis of these ”pseudohybrid“N-gly-
cans (53), which mirror the conventional hybrid structures
found in multicellular organisms, shows clearly that TbGnTII
can function without the prior action of TbGnTI.
The expression of TbGnTI is 40-fold higher in bloodstream-
form compared with procyclic-form T. brucei at the protein
level (35). This is consistent with the findings of Hwa and Khoo
(54), who did not detect hybrid or complex N-glycans in wild-
type procyclic forms. However, TbGnTI reaction products
have been found in procyclic-form cells after the selection of
ConA-resistant mutant clones (54, 55) and in procyclic-form
ALG12 and ALG3 null mutants, indicating that TbGnTI activ-
ity can be evoked in procyclic-form trypanosomes in response
to chemical or genetic challenges.
Finally, despite the significant changes in protein glycosyla-
tion brought about by deleting the TbGnTI (TbGT11) gene in
bloodstream-form T. brucei, the in vitro growth rate and infec-
tivity to mice of the null mutant were indistinguishable from
wild type. This contrasts with the RNAi knockdown of
TbSTT3A, the oligosaccharyltransferase responsible for trans-
ferring the biantennary Man5GlcNAc2 that is the precursor for
paucimannose and complexN-glycans inT. brucei. In that case,
the cells were viable in culture but not in mice (14). This clear
difference in in vivo virulence between theTbGnTI null mutant
and the TbSTT3A RNAi knockdown suggest that glycan exten-
sions to the 6-arm alone in the pseudohybrid N-glycan struc-
tures that are created in the TbGnTI null might be able to com-
pensate for those lost from the 3-arm. Whether the reverse is
truemust await identification of the gene(s) encoding TbGnTII
activity.
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